“Network Pharmacology and Molecular Docking Identify Eugenol As a Lead Compound Targeting Visceral Leishmaniasis Pathways With Nanotechnology-Driven Drug Design and Nanoscale Interaction Analysis”. Experimental and Theoretical NANOTECHNOLOGY, vol. 10, no. 3, July 2026, pp. 1449-68, https://doi.org/10.56053/10.3.1449.